CREATOGEN LAB GMBH has a total of 12 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ASCLEPIX THERAPEUTICS LLC, JIANG XI and TARGOVAX ASA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Brazil | 1 | |
#4 | China | 1 | |
#5 | Mexico | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Climate change adaptation technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Microorganisms | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Apfel Heiko | 9 |
#2 | Bumann Dirk | 3 |
#3 | Fuchs Thilo M | 1 |
#4 | Heiko Apfel | 1 |
Publication | Filing date | Title |
---|---|---|
WO2010094699A1 | Attenuated salmonella enteritidis strain | |
WO2010057983A1 | Salmonella marker vaccine | |
EP2189164A1 | Salmonella marker vaccine | |
EP1984022A2 | Influenza vaccine | |
EP1747012A2 | Preparation of salmonella broad-spectrum vaccines | |
WO2005058355A1 | Immune stimulation by administration of bacteria |